Geron Corp. (GERN) recent activity suggests a positive outlook with the last week’s performance of 2.84%

Geron Corp. (NASDAQ: GERN) kicked off on Friday, up 2.17% from the previous trading day, before settling in for the closing price of $4.60. Over the past 52 weeks, GERN has traded in a range of $1.64-$5.34.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 46.26% over the past five years. While this was happening, its average annual earnings per share was recorded -9.37%. With a float of $509.26 million, this company’s outstanding shares have now reached $544.91 million.

Let’s look at the performance matrix of the company that is accounted for 141 employees.

Geron Corp. (GERN) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp. is 15.62%, while institutional ownership is 58.02%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Corp Strategy & CCO sold 421,875 for $4.64, making the entire transaction worth $1,959,609. This insider now owns 0 shares in total.

Geron Corp. (GERN) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -9.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.

Geron Corp. (NASDAQ: GERN) Trading Performance Indicators

Take a look at Geron Corp.’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2068.00.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.15 in one year’s time.

Technical Analysis of Geron Corp. (GERN)

Geron Corp. (NASDAQ: GERN) saw its 5-day average volume 13.87 million, a positive change from its year-to-date volume of 11.46 million. As of the previous 9 days, the stock’s Stochastic %D was 63.51%. Additionally, its Average True Range was 0.27.

During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 72.05%, which indicates a significant decrease from 74.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.54% in the past 14 days, which was lower than the 60.21% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.53, while its 200-day Moving Average is $3.04. Nevertheless, the first resistance level for the watch stands at $4.80 in the near term. At $4.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.05. If the price goes on to break the first support level at $4.54, it is likely to go to the next support level at $4.38. The third support level lies at $4.28 if the price breaches the second support level.

Geron Corp. (NASDAQ: GERN) Key Stats

The company with the Market Capitalisation of 2.83 billion has total of 593,133K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -184,130 K annual income. Company’s last quarter sales were recorded 300 K and last quarter income was -55,390 K.